Nanomedicine News

RSS

Injectable Nano-Scale Electronic Scaffolds to Monitor Neural Activity

It's a notion that might be pulled from the pages of science-fiction novel - electronic devices that can be injected directly into the brain, or other body parts, and treat everything from neurodegenerative disorders to paralysis.

9 Jun 2015

Innovative Hand-Held Tool and App to Monitor for Signs of Skin Cancer Unveiled at World Dermatology Conference

Simon Fraser University PhD alumna Maryam Sadeghi is unveiling MoleScope™, an innovative hand-held tool that uses a smartphone to monitor skin for signs of cancer, at the World Congress of Dermatology conference in Vancouver June 9-13.

9 Jun 2015

NCI Nanotechnology Characterization Laboratory Selects Rexahn’s RX-21101 for Preclinical Characterization Program

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that its drug candidate RX-21101 was selected by the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL) for its preclinical characterization program to help facilitate the advance of RX-21101 towards human clinical trials.

9 Jun 2015

Nanotechniques Developed in Space Could Help Better Understand Deep Brain Stimulation

Applying nanotechniques developed in the U.S. space program may help to better understand the electrochemical dynamics of deep brain stimulation in order to fine-tune the therapy, according to a presentation by NASA Ames Research Center scientist Russell J. Andrews, M.D., at the International Neuromodulation Society’s 12th World Congress.

9 Jun 2015

Graphene-Coated Catheters May Improve Delivery of Chemotherapy Drugs

A new study published in IOP Publishing's journal 2D Materials has proposed using graphene as an alternative coating for catheters to improve the delivery of chemotherapy drugs.

3 Jun 2015

Global Antiviral Therapeutics Report Features Potential for Nanotechnology in Virology

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Antiviral Therapeutics - Technologies, Markets and Companies" to their offering.

2 Jun 2015

Dicerna’s DCR-MYC Demonstrates Clinical Anti-Tumor Activity Against Advanced Pancreatic Neuroendocrine Tumors

Dicerna Pharmaceuticals, Inc., a leader in the development of RNAi therapeutics, today presented preliminary safety and efficacy data from an ongoing Phase 1 study of DCR-MYC in patients with advanced solid tumors, multiple myeloma, or lymphoma at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting.

2 Jun 2015

Advances in Nanotechnology’ Event at Birmingham UK from 9 June

New technologies designed to eliminate cancers and aid surgical procedures are to be explored at an international nanotechnology conference in Birmingham next month.

1 Jun 2015

LD Micro Invitational: Matinas BioPharma to Present on Targeted Therapeutics

Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company"), a clinical-stage biopharmaceutical company principally focused on the development of targeted therapeutics for the treatment of infectious diseases, today announced that it will be presenting at the LD Micro Invitational being held June 1-3, 2015, at the Luxe Sunset Boulevard, Los Angeles, CA.

29 May 2015

Malvern's Nanoparticle Tracking Analysis Used in Development of Targeted microRNA Cancer Therapy at Ohio State University

Researchers in the Department of Chemical and Biomolecular Engineering at The Ohio State University (Columbus, Ohio, USA) are using Malvern Panalytical’ NanoSight Nanoparticle Tracking Analysis (NTA) to study extracellular vesicle yields from different cell culture lines.

From Malvern Panalytical 28 May 2015